Shopping Cart
Remove All
Your shopping cart is currently empty
Enzalutamide-d3 (Deutenzalutamide-d3) is a deuterium-labeled form of the androgen receptor antagonist enzalutamide, retaining potent anti-androgen and antineoplastic activity with an IC50 of 36 nM in LNCaP prostate cancer cells, and is primarily used in pharmacokinetic, metabolic tracing, and drug interaction studies.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $108 | 5 days | 5 days |
| Description | Enzalutamide-d3 (Deutenzalutamide-d3) is a deuterium-labeled form of the androgen receptor antagonist enzalutamide, retaining potent anti-androgen and antineoplastic activity with an IC50 of 36 nM in LNCaP prostate cancer cells, and is primarily used in pharmacokinetic, metabolic tracing, and drug interaction studies. |
| Targets&IC50 | Androgen receptor:21 nM |
| Synonyms | MDV3100-d3, MDV3100 D3, Deutenzalutamide-d3 |
| Molecular Weight | 467.45 |
| Formula | C21H16F4N4O2S |
| Cas No. | 1443331-82-5 |
| Smiles | S=C1N(C(C)(C)C(=O)N1C2=CC(C(F)(F)F)=C(C#N)C=C2)C3=CC(F)=C(C(NC([2H])([2H])[2H])=O)C=C3 |
| Relative Density. | no data available |
| Storage | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMSO: 20 mg/mL (42.79 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.